A 61-year-old woman is evaluated in the intensive care unit for a new fever and worsening … — USMLE Step 2 CK

A $61$ -year-old woman is evaluated in the intensive care unit for a new fever and worsening oxygenation. She was admitted $7$ days ago following a severe motor vehicle collision that resulted in multiple long-bone fractures and acute respiratory distress syndrome (ARDS) requiring endotracheal intubation. Her fraction of inspired oxygen ( $\text{FiO}_2$ ) had been weaned to $0.35$ , but over the past $24$ hours, it was increased to $0.60$ to maintain an oxygen saturation of $93\%$ . Her temperature is $38.8^\circ\text{C}$ ( $101.8^\circ\text{F}$ ), blood pressure is $110/65\text{ mm Hg}$ , and pulse is $115/\text{min}$ . The endotracheal tube is producing abundant, thick, greenish secretions. Auscultation reveals coarse rhonchi predominantly at the right lung base. A portable chest radiograph demonstrates a new consolidation in the right lower lobe.

Arrange the following management steps in the most appropriate sequence for this patient's current condition.

1Obtain an endotracheal aspirate or bronchoalveolar lavage sample for Gram stain and culture
2Administer empiric broad-spectrum intravenous antibiotics, such as vancomycin and cefepime
3Review final microbiological culture and susceptibility results at $48$ to $72$ hours
4De-escalate the antibiotic regimen to targeted, pathogen-specific therapy

Answer

The correct sequence is to first obtain respiratory cultures, immediately follow with empiric broad-spectrum antibiotics, reassess clinical and microbiological data at

48

72

hours, and finally de-escalate to targeted therapy.

The standard of care for ventilator-associated pneumonia involves a strict sequence to balance immediate life-saving treatment with responsible antimicrobial stewardship. A lower respiratory tract sample must be obtained first, as prior antibiotic administration rapidly decreases the yield of cultures. Immediately after sampling, empiric broad-spectrum antibiotics (covering MRSA and Pseudomonas) must be started, as delayed treatment increases mortality. At

48

72

hours, the initial cultures typically finalize, allowing the clinical team to safely de-escalate the broad-spectrum regimen to a targeted, narrow-spectrum agent.

Step-by-Step Solution

Recognize the clinical presentation of ventilator-associated pneumonia (VAP).

The patient has a new fever, purulent secretions, worsening oxygenation, and a new radiographic infiltrate after being intubated for

>48

hours.

Identifying VAP is the prerequisite for initiating the appropriate management protocol.

Prioritize diagnostic sampling.

Identify that cultures must be drawn first.

Antibiotics can alter culture results within hours; therefore, obtaining a sample (like an endotracheal aspirate) must precede antibiotic administration to guide future targeted therapy.

Initiate immediate empiric treatment.

Administer broad-spectrum antibiotics (e.g., vancomycin and cefepime) immediately after cultures are drawn.

Delaying therapy in VAP is associated with increased mortality, so empiric coverage for nosocomial pathogens is started without waiting for culture results.

Follow-up and perform antibiotic stewardship.

Review cultures at

48

72

hours and de-escalate to narrow-spectrum antibiotics.

Once the specific pathogen is identified, broad-spectrum agents should be narrowed to prevent multidrug resistance, minimize toxicity, and reduce costs.

Key Concept

The management of ventilator-associated pneumonia requires obtaining respiratory cultures prior to the prompt initiation of empiric broad-spectrum antibiotics, followed by de-escalation to targeted therapy once susceptibilities are known.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic